Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
PLYMOUTH MEETING, Pa., Feb 12, 2014 /PRNewswire/ -- ePharmaSolutions, a leading provider of eClinical solutions and specialty clinical services announced today that it has relocated its headquarters to Plymouth Meeting, PA. The relocation was to support the 40% increase in headcount as a result of doubling its sales from CY 2012. More than 20 new customers were added to its expanding list of biopharmaceutical clients with a 50% increase in enterprise eClinical software sales from the previous year.
"Our new facility is twice the square footage of our previous headquarters and supports our staff growth throughout 2013 with room for continued growth over the next few years," stated Keya Watkins, ePharmaSolutions' Sr. Vice President of Operations.
The company's continued growth is attributed to refining its service offerings and re-architecting its technology into a highly scalable and self-configurable cloud-based eClinical platform with integrated workflow "Apps" that can facilitate site feasibility and activation, study training, safety letter distribution, patient recruitment, remote monitoring, and eTMF (electronic trial master file). Each App is fully integrated within the eClinical platform allowing for centralization of study related tasks (approval of documents, visit reports, training, etc.) for study teams and site users. The integration also supports a completely electronic clinical document management process from the sites to the eTMF to the publishing application using digital signature, tablet based document capture, and/or 2D Bar Code intelligent routing.
"Clients can deploy our solution at the enterprise or study level, select the 'Apps' they want for each study, and configure a study in less than a day, making the process simple and fast for study teams to facilitate the set-up of complex global clinical trials," added Ms. Watkins.
ePharmaSolutions reached several important goals in 2013 by launching its ReferralPlus patient recruitment program, initiating its CRO Partnership Program, launching several new Apps to its platform, and winning the 2013 Microsoft Life Sciences Innovation Award, the 2013 Bio-IT World "Best In Show" Award and being profiled by CenterWatch as one of the Top 20 Innovators in the Clinical Trials Industry.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions has won multiple industry awards for its eClinical platform which now hosts more than 300,000 clinical researchers in 130 countries for the leading pharmaceutical companies and CROs. ePharmaSolutions is headquartered in Plymouth Meeting, PA with offices in Slough, UK. ePharmaSolutions new address is 1 IMS Drive, Suite 200, Plymouth Meeting, PA 19462.
For more information, visit us at www.epharmasolutions.com.
©2012 PR Newswire. All Rights Reserved.